Kobey

Ezetimibe, the active ingredient in Kobey, is a cholesterol absorption inhibitor presented as an oral dosage form for oral use. It reduces the absorption of dietary and biliary cholesterol and is used to manage elevated cholesterol levels in adults with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and other lipid disorders.

GNH USA supplies Kobey as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kobey (ezetimibe) acts on cholesterol metabolism to lower lipid concentrations in the blood. - Hypercholesterolemia: lowers total and LDL‑cholesterol levels. - Heterozygous familial hypercholesterolemia: helps achieve target cholesterol reductions when used alone or with statins. - Primary hyperlipidemia: contributes to overall lipid profile improvement as part of a therapeutic regimen.

Ezetimibe is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: occasional loose stools. - Abdominal pain: discomfort in the stomach area. - Fatigue: feeling of tiredness. - Arthralgia: joint pain. - Upper respiratory tract infection: mild cold‑like symptoms.

Serious or Rare Side Effects: - Myopathy: muscle pain or weakness, especially when combined with statins. - Elevated liver enzymes: possible hepatic injury. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Pancreatitis: abdominal pain with nausea. - Cholestatic hepatitis: jaundice and liver dysfunction.

Before initiating therapy, consider the following safety measures. - Liver function monitoring: assess baseline and periodic liver enzymes. - Pregnancy assessment: evaluate risks and benefits before use in pregnant patients. - Concomitant statin therapy: monitor for muscle-related symptoms. - Renal function evaluation: adjust use in severe renal impairment. - Patient counseling: advise on recognizing signs of myopathy or liver injury. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ezetimibe may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Cyclosporine: increases ezetimibe plasma concentrations; avoid co‑administration.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin, atorvastatin): heightened risk of myopathy; monitor muscle symptoms. - Warfarin: possible alteration of INR; check coagulation status regularly. - Antacids (e.g., aluminum hydroxide): may reduce ezetimibe absorption; separate dosing times. - Bile acid sequestrants (e.g., cholestyramine): can lower ezetimibe effectiveness; stagger administration.